UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Galvin Gaustad & Stein LLC

Galvin Gaustad & Stein LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.3% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 60,167 shares of the healthcare conglomerate’s stock after selling 806 shares during the period. UnitedHealth Group makes up 2.7% of Galvin Gaustad & Stein LLC’s holdings, making the stock its 5th biggest holding. Galvin Gaustad & Stein LLC’s holdings in UnitedHealth Group were worth $30,436,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in UNH. APG Asset Management US Inc. increased its stake in shares of UnitedHealth Group by 5.3% during the second quarter. APG Asset Management US Inc. now owns 351,983 shares of the healthcare conglomerate’s stock worth $174,108,000 after buying an additional 17,747 shares during the period. Ameriprise Financial Inc. increased its position in shares of UnitedHealth Group by 0.6% in the 2nd quarter. Ameriprise Financial Inc. now owns 3,772,487 shares of the healthcare conglomerate’s stock valued at $1,920,039,000 after purchasing an additional 21,149 shares during the last quarter. Employees Retirement System of Texas lifted its position in shares of UnitedHealth Group by 9.2% during the 2nd quarter. Employees Retirement System of Texas now owns 198,670 shares of the healthcare conglomerate’s stock worth $101,175,000 after purchasing an additional 16,800 shares during the last quarter. Eminence Capital LP purchased a new position in UnitedHealth Group in the second quarter valued at $26,657,000. Finally, Drucker Wealth 3.0 LLC purchased a new stake in UnitedHealth Group during the 2nd quarter worth about $1,062,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Truist Financial decreased their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. UBS Group lowered their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Oppenheimer boosted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Stephens lifted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $627.74.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $528.94 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm’s 50-day simple moving average is $543.52 and its 200 day simple moving average is $563.78. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a market capitalization of $486.77 billion, a PE ratio of 34.12, a P/E/G ratio of 1.41 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $5.83 EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.74 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were paid a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.59%. UnitedHealth Group’s payout ratio is currently 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.